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Abstract 
Background 
The use of Transcatheter Aortic Valve Replacement (TAVR) is increasing 
worldwide. We present our 6-year experience using 3-D TEE and investigate if 
different sizing methods of the aortic annulus lead to different prosthesis size that 
may impact on outcome. 
Methods 
We investigated 262 patients who underwent TAVR and had 3D TEE datasets 
of the aortic annulus. We have used the area-derived diameter (Darea=2√(𝑎𝑟𝑒𝑎/𝜋) ) 
and the circumference-derived diameter (Dcirc=Circumference/π) to size the prosthesis 
in separate populations in different time periods.  
Results 
The Dcirc-method is correlated with lower incidence of paravalvular aortic 
regurgitation (PVAR) (OR:0.44, 95% CI: 0.23-0.85; p=0.015). Other factors associated 
with PVAR were the cover index, area-mismatch index and circumference-mismatch 
index. 
Retrospectively, for the purposes of the study, we used the Edwards-Sapien 3 
Valve 3D-Sizing Guide in all patients, to predict the hypothetical valve size with each 
method. In the whole population, the calculated Dcirc was higher in all cases (Dcirc = 
23.4 ± 2.3mm vs Darea = 22.9 ± 2.3mm; p < 0.001). The two methods had good 
agreement in predicting the valve size (kappa = 0.600). 192 (73.3%) patients were 
assigned for the same prosthesis size, whereas 70 (26.7%) would be eligible for a 
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different size, of which 44 (16.7%) would definitely have had a different valve 
implanted. 
Conclusion 
Using the aortic annulus area or circumference to calculate the annular 
diameter provides different values. Comparing the two methods, a different 
prosthesis size could have been implanted in 26.7% of patients. In our series the use 
of circumference-derived diameter resulted in lower incidence of PVAR.  The findings 
of this study may be independent of the imaging modality and may therefore also 
apply to CT based aortic annulus measurements, but this needs to be further 
investigated. 
 
Key words: transcatheter aortic valve replacement (TAVR), 3D 
echocardiography, aortic annulus, paravalvular aortic regurgitation, aortic valve size 
 
Abbreviations 
3D: Three-dimensional 
AR: Aortic Regurgitation 
AS: Aortic Stenosis 
AV: Aortic Valve 
CI: Cover Index 
CT: Computed Tomography 
Davg: Average Diameter 
Darea : Area-derived effective diameter 
Dcirc : Circumference-derived effective diameter 
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ER: Eccentricity Ratio 
LVOT: Left Ventricular Outflow Tract 
PVAR: Paravalvular Aortic Regurgitation 
TAVR: Transcatheter Aortic Valve Replacement 
TEE: Transesophageal Echocardiography 
TTE: Transthoracic Echocardiography 
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1.  Introduction 
Transcatheter Aortic Valve Replacement (TAVR) is a validated treatment for 
symptomatic severe aortic stenosis (AS) in inoperable or high risk surgical patients [1]. 
Accurate sizing of the aortic valve (AV) prosthesis is paramount to ensure acute 
success and a durable long-term outcome. Many procedures are performed utilising 
2D transthoracic (TTE) or Transesophageal (TEE) echocardiographic measurements of 
the aortic annulus [2, 3]. These measurements assume that the shape of the aortic 
annulus is circular. However, since the aortic annulus is usually oval-shaped, it has 
become apparent that making a single diameter measurement from 2D images will 
result in erroneous dimensions. 
This has led to the use of multi-slice CT and three-dimensional (3D) TEE imaging 
to size the aortic annulus, since they can both account for irregular, non-circular 
annular shapes. Planimetry of aortic annulus in 3D orientated images improves 
annulus measurements, and good agreement has been reported between multi-slice 
computed tomography and 3D TEE [4, 5]. The sizing guide for the most recent 
commercially available balloon-expandable valves is based on 3D annular area and 3D 
area-derived diameter. However, as the shape of the annulus becomes more ellipsoid, 
the area shrinks but the circumference remains unchanged. In this study we test the 
hypothesis that sizing the aortic annulus using the circumference, as opposed to the 
area, may lead to different prosthesis size choice, especially in patients with 
significantly ellipsoid shape of the aortic annulus, and we seek to investigate possible 
clinical implications. 
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2. Material and methods 
2.1. Study population 
A total of 294 patients were referred to our centre for TAVR between 
September 2009 and May 2014. They presented with symptomatic, severe valvular 
calcific aortic stenosis and were reviewed by a multi-disciplinary team. A total of 11 
patients were excluded from the study. Seven of those patients presented with a 
failing aortic valve bioprosthesis and were considered for a valve in valve procedure. 
One had a metallic mitral valve prosthesis which did not allow adequate TEE imaging 
and underwent a gated, multi-slice CT for prosthesis sizing. Three patients developed 
an iatrogenic ventricular septal defect or Gerbode defect and therefore paravalvular 
AR (PVAR) could not be accurately quantified. The implanted valves were the Edwards 
Sapien XT (179 patients), the Edwards-Sapien 3 (83 patients), the Boston Scientific 
Lotus valve (17 patients) and the Jenavalve (4 patients). The Lotus and Jenavalve 
valves are deployed with a controlled mechanical expansion as opposed to the 
Edwards balloon-expanded valves. This difference along with the different sizing 
recommendations may pose a bias to the explored outcome (paravalvular aortic 
regurgitation) and therefore the patients with a Lotus or Jenavalve prosthesis were 
excluded, and we only studied patients with Edwards-Sapien valves. All patients 
signed an informed consent for the therapeutic and diagnostic procedures, which 
included 3D TEE.  
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2.2 Echocardiographic study 
Transesophageal Echocardiography was performed in all patients as part of the 
pre-procedural work-up to ensure suitability for the intervention, as is standard 
practice in our centre. In addition, all patients had peri-procedural TEE for guidance 
and monitoring of complications [2]. The ultrasound systems iE33 and Epiq7 (Philips 
Healthcare, Andover, MA, USA) with a matrix array probe (X7-2t) and the Vivid 9 (GE 
Healthcare, Hertfordshire, UK) with the 6VT-D transducer, to allow for 2D and 3D live 
images, were used. The aortic valve and the ascending aorta were studied in short axis 
(mid-oesophageal, 40o-70o) and long axis views (mid-oesophageal, 110o-135o) and 2D 
images with and without colour Doppler obtained and stored in the hospital 
cardiology imaging archive (Philips, Xcelera). Using the “3D zoom” feature, 3D datasets 
of the AV, including the LVOT and proximal ascending aorta (sinuses and sinotubular 
junction), were acquired. A single-beat acquisition was used. 
2.3 Echo image analysis 
The 3D datasets were analyzed off-line with the Philips Qlab (QLAB cardiac 
3DQ, Philips Medical Systems, versions 9, 10) or online on GE machines (GE 
Healthcare, Hertfordshire, UK). The measurements were made in a mid-systolic frame. 
Three multiplanar reconstruction planes (MPR) were used. Two were bisecting the 
long axis of the left ventricular outflow tract (LVOT) and were orthogonal to each other 
in the sagittal and coronal planes. The third one was transverse to the previous ones 
and was intersecting the aortic valve in its short axis at the level of the annulus (Figure 
1). Special care was taken to position the transverse MPR at the level just below the 
hinge point of all three aortic cusps. One experienced operator performed a manual 
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tracing of the aortic annulus in this transverse plane and also measured the maximum 
and minimum diameters (Dmax and Dmin respectively).  This analysis methodology is 
analogous to that performed using CT datasets. 
The aortic valve was assessed with both 2D and 3D echo datasets and the 
degree of calcification was graded as moderate or severe. There were no cases with 
mild valvular calcification. The AV was considered as severely calcified if all cusps 
demonstrated considerably increased echogenicity in more than 50% of their tip 
surface and there was also significant calcification affecting the commissures between 
cusps or there was eccentric calcification on cusps measuring more than 5mm [6] 
(Figure 2). The cases with lower echogenicity and thickening of the aortic cusps were 
graded as having moderate calcification.   
The post-procedural paravalvular aortic regurgitation (PVAR) was graded by 
echocardiography (both TEE and TTE) according to recently published guidance [7].  
Using the semi-quantitative method of circumferential extent of the PVAR jets, the 
quantitative width of jet at its origin and the ratio of the jet width to LVOT diameter, 
the PVAR was classified in a five-grade scheme (mild, mild to moderate, moderate, 
moderate to severe, and severe) [7].  
2.4. Measurements and calculations 
 The effective annulus diameter was calculated from the annular area and 
circumference according to the equations: 
Area-derived effective diameter (Darea): (Darea = 2√(𝑎𝑟𝑒𝑎/𝜋) ) 
Circumference-derived effective diameter (Dcirc): Dcirc = Circumference/π 
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As part of our protocol we had been using the Darea to size the TAVR prosthesis 
until April 2013, whereas since then we have been using the Dcirc to select an 
appropriately sized prosthesis taking into account sinus dimensions and the valve 
calcification. The manufacturer provides different recommendations for oversizing 
each valve (Sapien XT and Sapien 3). We followed these oversizing recommendations 
for the different valves in both groups (Darea and Dcirc).  
The Eccentricity Ratio (ER) was calculated as ER = 1 – (Dmin/Dmax) [8, 9].  The 
average diameter (Davg) was derived by the sum of Dmax and Dmin divided by two. 
We calculated the cover index (CI) using the average annulus diameter in the equation 
[10]:  
CI = 100 x (Prosthesis Diameter–TEE Average Annulus Diameter)/Prosthesis 
Diameter 
Finally we used the 3D tracing of the aortic annulus to calculate the Mismatch 
Indices such as:  
Area Mismatch Index = TEE planimetered annulus area – prosthesis area [6], 
and 
Circumference Mismatch Index = TEE planimetered annulus circumference – 
prosthesis circumference. 
For the purposes of this study we retrospectively, performed a theoretical 
prosthesis sizing utilizing the 3D sizing guide for a new generation balloon-expandable 
valve (The Edwards-Sapien 3 Valve) to determine the prosthesis size in the whole 
population. We used this sizing guidance for both Darea and Dcirc measurements. This 
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aimed to investigate the hypothesis that in the same individuals, the diameter derived 
by the aortic annulus circumference may result in a different prosthesis size compared 
to the area-derived diameter. This was a hypothetical retrospective comparison after 
the TAVR procedure, and it was not used for clinical decision making. 
Finally, we assessed the interobserver variability of aortic annulus 
measurements. For this purpose, we asked a second experienced operator to retrace 
twenty cases. The second operator was blind to the exact 3D datasets and the frames 
used by the first operator as multiple datasets were acquired per patient. He also 
performed independently the alignment of axes in the multiplanar reconstruction 
planes.  
2.5. Statistical analysis 
Statistical analysis was performed using SPSS for Windows (version 20.0, IBM 
Corporation Software GroupSomers, NY, USA). Continuous variables were 
summarised   as mean ± standard deviation. The continuous variables were normally 
distributed based on histograms. Differences between paired samples of continuous 
variables were tested using the paired t-test and between independent samples 
utilizing the unpaired student t-test. The comparison of two methods to determine 
the prosthesis size was performed with Cohen’s kappa. Uni- and multi-variable logistic 
regression analyses were used to assess the correlation of several parameters with 
paravalvular aortic regurgitation. We have used a binary variable for PVAR in the 
analysis: “no PVAR” and “mild or greater PVAR”. The goodness of fit of the model was 
tested with the Hosmer-Lemeshow test and was found to be adequate. The multi-
collinearity of the variables was tested with linear regression and an R square value 
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above 0.7 was considered suggestive of positive correlation. The interobserver 
variability was investigated with the intraclass correlation coefficient for a two-way 
mixed model. Statistical significance was considered for a two-tailed p-value < 0.05. 
3. Results 
3.1. Baseline characteristics and outcome 
We divided the study population into two groups based on the method used 
to size the AV prosthesis (Darea vs Dcirc). The baseline characteristics of the two groups 
are presented in Table 1. One hundred and thirty-nine patients (53.1%) had mild AR 
at pre-assessment, 9 had moderate AR and none had severe. The majority of patients 
received 23 and 26 mm valves (114 patients; 43.5% and 108 patients; 41.2% 
respectively); 37 patients (14.1%) had a 29mm valve implanted and 3 patients had a 
20mm valve (1.1%). In 79 (30.2%) patients a transapical/transthoracic approach was 
used, whereas 180 (68.7%) had a transfemoral procedure and in 3 patients (1.1%) the 
valve was implanted through transaortic access. Post-procedure, 96 (36.6%) patients 
had mild paravalvular AR (PVAR) and 10 (3.8%) had mild to moderate. In terms of 
simplicity these 106 patients formed a common group of “mild or greater” PVAR. 
There were no patients with moderate, moderate-to-severe, or severe PVAR.  
3.2. Sizing AV prosthesis using the annular circumference vs area. 
Applying retrospectively the manufacturer’s guiding size for the new 
generation balloon-expandable valve in all patients, the two methods (Darea and Dcirc) 
had good agreement in predicting the valve size (kappa=0.600). 192 patients (73.3%) 
were assigned for the same valve size prosthesis by both methods (Table 2).  However, 
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70 patients (26.7%) were allocated to a different size group. 26 of those patients 
(9.9%) would be eligible for a different size as they were allocated in the overlapping 
groups (23 or 26mm and 26 or 29mm groups). Importantly, 44 patients (16.7%) would 
definitely have had a different valve implanted. All patients assigned to a different 
group would have had a larger prosthesis based on the Dcirc compared to Darea, 
including 22 (8.4%) patients who would have been excluded from TAVR if prosthesis 
selection would have been performed based on Darea (diameter < 20.0mm). This is not 
surprising, as in the whole study population the effective diameter by circumference 
was higher in all cases compared to area-derived diameter (23.4 ± 2.3mm vs 22.9 ± 
2.3mm; p < 0.001). There were no patients considered to have too big annulus 
diameter for TAVI prosthesis, as calculated by both methods. 
3.3. Factors associated with paravalvular AR 
We sought to investigate factors associated with paravalvular AR (PVAR) post-
TAVR in the whole cohort (Table 3). Minimum diameter, average diameter and 
annulus area demonstrated multi-collinearity so only the minimum diameter which 
showed a lower p value is shown in Table 3. Similarly, the peak and mean pressure 
gradients and the peak velocity demonstrated multiple collinearity and only peak 
velocity is included. In univariate analysis, the aortic valve area, the cover index, the 
area and circumference mismatch indices, the type of valve used and the method of 
sizing the aortic annulus were found to be correlated with PVAR. The new generation 
Sapien 3 valves were found to be associated with lower risk of PVAR compared to the 
Sapien XT valve. The sizing method using the Dcirc as opposed to the Darea was related 
with lower risk of PVAR.  
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All parameters with a p value < 0.2 were included in a multi-variable model. 
The cover index, the area and the circumference mismatch indexes were significantly 
correlated to each other. We used them interchangeably in the multivariable model 
as they were all significantly related to PVAR in uni-variable analysis. The factors 
associated independently with PVAR after adjusted for aortic valve area, peak velocity, 
valve calcification and minimum diameter, were the cover index (OR: 0.91; 95% CI: 
0.86-0.96; p < 0.001), the type of TAVR prosthesis and the sizing method (Table 4). The 
older generation valve (Sapien XT) was related with higher risk of PVAR compared to 
the new generation valves (OR:2.39; 95% CI:1.08-5.32; p=0.032). The use of annulus 
circumference to size the prosthesis had a more favourable outcome in terms of PVAR 
which was independent of other factors (OR:0.44; 95% CI:0.23-0.85; p=0.015). The 
area mismatch index was also related to PVAR (OR:2.75; 95% CI:1.64-4.63, p<0.001) 
when inserted in the multi-variable logistic regression model and the other factors 
(prosthesis type and sizing method) maintained correlation with PVAR. When we used 
the circumference mismatch index it was found to be independently associated with 
PVAR as well (OR:2.83; 95% CI:1.52-5.27, p=0.001), along with the sizing method and 
the type of prosthesis. 
3.5 Interobserver variability 
The ICC for absolute agreement of single measures for Dmax, Dmin, and Davg 
was 0.660 (95%CI: 0.315-0.851), 0.841 (95%CI: 0.645-0.934) and 0.813 (95%CI: 0.572-
0.923) respectively. For the annulus area and circumference the ICC was 0.844 (95%CI: 
0.631-0.937) and 0.856 (95%CI: 0.630-0.940) respectively. 
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4. Discussion 
The primary findings of our study are: a) sizing the aortic prosthesis using the 
annulus circumference-derived diameter as opposed to area-derived diameter, would 
result in a potentially different prosthesis size in 26.7% of patients using a theoretical 
single sizing guide, b) the use of annulus circumference (Dcirc) to size the TAVI 
prosthesis results in significantly lower prevalence of PVAR without additional risks 
compared to the sizing method using annular area (Darea), c) the cover index, the area 
mismatch index and the circumference mismatch index are all associated 
independently with PVAR. 
Hahn et al. [11] propose a sizing algorithm using the annular area for the 
balloon-expandable valves and the cardiac CT expert consensus recommendations 
provide guidance for CT-based sizing of self-expanding valve using the mean diameter, 
the area or the circumference of the aortic annulus [12]. A manufacturer of a new 
generation balloon-expandable valve (Edwards Sapien 3) provides a sizing guide and 
suggests using the 3D annular area and 3D area-derived diameter to select the correct 
TAVI prosthesis.  
We have incorporated the circumference-derived diameter into our TAVI 
protocol to select prosthesis size, and we tested the hypothesis that this method may 
have an impact on the prosthesis size when compared to an area based calculation. 
The aortic annulus is often not circular or more precisely is seldom a perfect circle in 
shape [13]. Therefore, annuli of the same area may have a different circumference 
depending on the annulus shape. In Figure 3 we present an example of circular and 
elliptical annular shapes with the same area but a different circumference. The area-
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derived diameters will be identical in both cases leading to the use of an identical 
prosthesis size despite the different shape of the annulus. On the contrary, the 
circumference-derived diameters will be different in both cases which could possibly 
lead to the selection of a different prosthesis size. Indeed, according to our results 
26.7% of 262 patients would be potentially candidates for a different prosthesis size if 
one method was used as opposed to the other. 
The critical question is whether the discrepancy between the two methods of 
annulus sizing may have an impact on clinical outcome. Our study was not designed 
to investigate the clinical outcome in TAVR patients, but it is well-known that under-
sizing or over-sizing the prosthesis may have significant adverse results [14] and 
furthermore significant paravalvular AR has been reported to have negative impact on 
long-term outcome [15]. We investigated the prevalence of PVAR in our population 
and we concluded that the odds for patients who receive a prosthesis based on Darea 
were 2.4 times higher for developing paravalvular aortic regurgitation as opposed to 
Dcirc. This finding is independent of other known predictors of PVAR like cover index 
or area mismatch index [10, 6]. However, the very limited use of new generation 
valves in the Darea group may remain a confounder. Despite the results of the multi-
variable analysis we sought to investigate this further. In the Dcirc group (N=135) we 
used the Sapien XT valve in 57 patients (42.2%) and the Sapien 3 in 78 (57.85%). We 
performed a sub-group analysis only in this group and the type of valve was not found 
to be related to PVAR in univariable analysis (OR: 1.32, 95% CI:0.612-2.844, p=0.479). 
Additionally, we investigated only the patients who received a Sapien XT valve 
(N=179). In a multi-variable model, the sizing method was found again to be 
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significantly related to PVAR (OR: 0.420, 95%CI: 0.199-0.884; p=0.022) along with the 
cover index (and interchangeably the area and circumference mismatch indices) (OR: 
0.904; 95% CI:0.844-0.969, p=0.004).  
There is no similar comparison between the two methods in the literature and 
although this is not a randomised clinical trial we believe that these findings are of 
great relevance to clinicians and the industry when considering prosthesis-sizing for 
TAVI procedures.  We have recorded three cases of patients who developed 
complications which may be related to valve oversizing. Two of them were in the Darea 
group and 1 in the Dcirc group. These patients were excluded from the study due to 
inherent difficulties in assessing the PVAR. Despite the small number of complications 
there was no increased risk of oversizing the prosthesis associated with the use the 
Dcirc in our series. Overall, the better outcome, in terms of PVAR, of patients who had 
a prosthesis sized by Dcirc, can be explained by the fact that the circumference-derived 
diameter corrects for the ellipsoid shape of the annulus, a factor that has been related 
to PVAR in previous studies [16].   
Another finding of our study is that low cover index is associated with 
paravalvular AR in an adjusted model. This is in consistency with a previously 
published study by Detaint et al. [10]. Also the area mismatch index is an independent 
predictor of PAVR and Gripari et al [17], report similar findings using the “area cover 
index” defined as the percentage difference between planimetered annulus area and 
the nominal prosthesis area (1 – Annulus area/Prosthesis nominal area). Additionally, 
we tested the circumference mismatch index which also showed significant and 
independent correlation with PVAR. 
18 
 
Based on the results of our study it seems that the type of prosthesis is 
associated with PVAR. The new generation Sapien 3 valve was related to lower degree 
of PVAR compared to the Sapien XT valve. However, this finding is possibly related to 
the very small numbers of Sapien 3 valves used in the Darea group. Also, our study was 
not powered to make comparisons between valves. Therefore, these results are 
limited by significant statistical bias and no definite conclusions can be made.  
In our study the aortic valve calcification was not correlated with PVAR. 
Jilaihawi et al. [18] using CT, demonstrated that valve calcification is an independent 
predictor of PVAR and leaflet calcium volume greater than 234 mm3 can predict PVAR. 
Gripari et al. [17] demonstrated that the calcification between the right and non-
coronary cusps as assessed with TEE, is an independent predictor of PVAR. However, 
Jilaihawi et al. [19] in another study with CT did not confirm correlation of AV 
calcification with PVAR using a semi-quantitative method. Santos et. al. [6] report that 
AV calcification in TEE was not related to PVAR using a semi-quantitative method 
similar to ours. These discrepancies in literature probably reflect the limitations and 
bias of semi-quantitative methods.  
This is a single center study with the inherent limitations and bias. We have 
used current recommendations to assess PVAR [7], which may have some limitations 
as they are based in 2D color tomographic planes, therefore may not accurately 
estimate the 3D anatomic and spatial characteristics of the regurgitant jet. It is worth 
stating again, that in our population, there were no patients with moderate, 
moderate-to-severe or severe PVAR based on the 5-grade schemed we used [7]. A 
more simple system for grading PVAR could have also been used (i.e. mild, moderate 
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and severe PVAR), which actually may be more functional in clinical practice. The 
method of sizing the TAVR prosthesis is associated with PVAR in our study, but this is 
an observational study, with retrospective design and is therefore hypothesis-
generating, which is a significant limitation. The assignment of patients to sizing 
method groups was not made randomly but was based on our center’s protocol in two 
separate chronological periods. The Darea method was used earlier in time. Therefore, 
it may be claimed that the better outcome in the Dcirc group may just reflect the 
learning curve of the operators, which is an important limitation. However, the team 
involved in the TAVI procedures in our center has remained unchanged since 2007 and 
there was a 2-year experience with 64 cases prior to the beginning of this study. The 
assessment of valve calcification was made using a semi-quantitative method, 
therefore was subjective and operator dependent.  We did not take into account the 
effect of procedural factors such as balloon volume for the Sapien S3 valve and the 
depth of prosthesis implantation. All annulus measurements were performed in 3D 
TEE images and there was no direct comparison with CT measurements. However, 
good correlation has previously been described between 3D TEE and CT 
measurements [4, 5, 20]. Ng et al. [4] have demonstrated that 3D TEE underestimates 
the aortic annulus area compared to CT. Based on that, one may assume that the Dcirc 
method cancels out this underestimation resulting in less PVAR. However, Tamborini 
et al. [20] showed very good agreement between 3D TEE and CT measurements. Our 
findings may equally apply to CT based annulus measurements, but certain 
conclusions cannot be made. Finally, we assessed only balloon-expandable valves 
(Edwards Sapien XT and Sapien 3), and extrapolation of results for self-expanding 
valves cannot be made. Ideally, a randomized trial with present generation prostheses 
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would be the best way to address our hypothesis about prosthesis sizing. However, 
the rapid evolution of TAVR valve types may always render such a study difficult to 
assess contemporary valves, unless it is designed in a multi-center fashion. 
5. Conclusion 
Accurate assessment of the aortic annulus is paramount for a successful result 
in TAVR procedures. However, there are several methods used for sizing the aortic 
annulus and manufacturers provide guidance based on annular area and diameter. In 
this study we demonstrate that if the circumference-derived diameter, was used to 
select the TAVR prosthesis, as opposed to area-derived diameter, one out of four 
patients would have had TAVR of a different sized prosthesis. The sizing method using 
the circumference-derived diameter results in a lower incidence of paravalvular aortic 
regurgitation. The correlation of the sizing method with paravalvular aortic 
regurgitation is independent of other factors like cover index, area mismatch index 
and circumference mismatch index. Our findings suggest that sizing the TAVR 
prosthesis by aortic annulus area measurements may have geometrical drawbacks 
which can be eliminated by using annulus circumference measurements. However, 
whether this holds true with the use of new generation valves, needs to be further 
investigated. 
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Tables 
Table 1. Baseline characteristics in the groups of the two different methods for sizing 
the prosthesis 
  Prosthesis Sizing     
  
Based on Darea 
(N=127) 
Based on Dcirc 
 (N=135) 
p value 
All 
(N=262) 
Age 84.4 ± 5.9 82.5 ± 6.6 0.011 83.4 ± 6.3 
Gender (male) 57 (44.9%) 69 (50.7%) 0.313 126 (48.1%) 
Aortic Valve Area (cm2) 0.70 ± 0.20 0.74 ± 0.20 0.058 0.72 ± 0.20 
Peak Pressure Gradient (mmHg) 75.7 ± 22.9 73.3 ± 23.8 0.404 74.5 ± 23.4 
Mean Pressure Gradient (mmHg) 42.8 ± 14.9 41.8 ± 14.1 0.564 42.3 ± 14.5 
Maximum Velocity (m/sec) 4.3 ± 0.7 4.2 ± 0.7 0.268 4.3 ± 0.7 
Baseline AR   0.204  
No AR 63 (49.6%) 51 (37.8%)  114 (43.5%) 
Mild 60 (47.2%) 79 (58.5%)  139 (53.1%) 
Moderate or Severe 4 (3.1%) 5 (3.7%)  9 (3.4%) 
Severe AV calcification 44 (34.6%) 42 (31.1%) 0.543 86 (32.8%) 
Maximum diameter (mm) 24.7 ± 2.7 25.1 ± 2.8 0.162 24.9 ± 2.8 
Minimum diameter (mm) 20.6 ± 2.2 20.6 ± 2.5 0.909 20.6 ± 2.4 
Average diameter 22.6 ± 2.3 22.9 ± 2.4 0.372 22.8 ± 2.3 
Eccentricity Index (1-Dmin/Dmax) 0.16 ± 0.07 0.18 ± 0.09 0.138 0.17 ± 0.08 
Annular Area (cm2) 4.10± 0.82 4.20 ± 0.84 0.361 4.15 ± 0.83 
D-area (mm) 22.8 ± 2.3 23.0 ± 2.3 0.366 22.9 ± 2.3 
Annular Circumference (cm) 7.28 ± 0.72 7.41 ± 0.75 0.144 7.35 ± 0.74 
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D-circ (mm) 23.2 ± 2.3 23.6 ± 2.4 0.145 23.4 ± 2.3 
Cover Index  8.81 ± 6.84 9.11 ± 5.90 0.710 8.96 ± 6.37 
Area Mismatch Index -0.77 ± 0.64 -0.85 ± 0.57 0.335 -0.81 ± 0.61 
Circumference Mismatch Index -0.52 ± 0.54 -0.52 ± 0.48 0.918 -0.52 ± 0.50 
Valve type   < 0.001  
Sapien XT 122 (96.1%) 57 (42.2%)  179 (68.3%) 
Sapien 3 5 (3.9%) 78 (57.8%)  83 (31.7%) 
Transfemoral approach 72 (56.7%) 108 (80.0%) < 0.001 180 (68.7%) 
Mild or greater PVAR 70 (44.9%) 36 (26.7%) < 0.001 106 (40.5%) 
 
Darea: Area-derived diameter, Dcirc: Circumference-derived diameter, AR: Aortic regurgitation, 
AV: Aortic valve, PVAR: Paravalvular aortic regurgitation 
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Table 2. Allocation of patients in prosthesis size groups based on effective diameter 
derived by the circumference or the area of aortic annulus. 
  Valve size by Dcirc   
Valve size by 
Darea 
Too small 23 mm 
23 or 26 
mm 
26 mm 
26 or 29 
mm 
29 mm Total 
Too small 7 22 0 0 0 0 29 
23 mm 0 106 6 11 0 0 123 
23 or 26 mm 0 0 0 10 0 0 10 
26 mm 0 0 0 59 6 11 76 
26 or 29 mm 0 0 0 0 0 4 4 
29 mm 0 0 0 0 0 20 20 
Total 7 128 6 80 6 35 262 
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Table 3. Uni-variable logistic regression analysis of possible factors associated with 
mild or greater paravalvular aortic regurgitation following TAVR.  
 
 
  
 
 
 
 
 
 
 
 
 
AR: aortic regurgitation, OR: odds ratio 
 
 
 
 
Variables OR (95% CI) p value 
Age 1.02 (0.98-1.06) 0.295 
Gender (male) 0.73 (0.44-1.20) 0.210 
Aortic Valve Area 0.20 (0.05-0.73) 0.015 
Peak Velocity 1.45 (0.99-2.13) 0.059 
Greater than mild baseline AR 1.88 (0.49-7.18) 0.355 
Severe AV calcification 1.56 (0.92-2.62) 0.097 
Maximum diameter 1.05 (0.96-1.15) 0.284 
Minimum diameter 1.08 (0.97-1.20) 0.163 
Eccentricity Index (1-Dmin/Dmax) 0.43 (0.18-10.30) 0.598 
Annular Circumference 1.14 (0.82-1.60) 0.433 
Cover Index  0.91 (0.87-0.95) <0.001 
Valve type (Sapien XT vs Sapien 3)  2.67 (1.50-4.75) 0.001 
Sizing method (Dcirc vs Darea) 0.30 (0.18-0.50) <0.001 
Transfemoral approach 0.84 (0.49-1.44) 0.531 
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Table 4. Multi-variable logistic regression analysis of factors associated with mild or 
greater paravalvular aortic regurgitation following TAVR.  
 
 
 
 
 
  
Variables OR (95% CI) p value 
Cover Index  0.91 (0.86-0.96) < 0.001 
Valve type (Sapien XT vs Sapien 3)  2.39 (1.08-5.32) 0.032 
Sizing method (Dcirc vs Darea) 0.44 (0.23-0.85) 0.015 
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Figure Legends 
Figure 1. Aortic annulus measurements in a 3D Trans-esophageal echocardiography 
dataset. 
Figure 2. Long axis view of the aortic valve showing significant eccentric calcification 
on non-coronary cusp. 
Figure 3. Typical examples of circular and ellipsoid aortic annulus shapes. Despite the 
difference in shape, the annular circumference is identical in both cases whereas the 
area is smaller in the ellipsoid shape. 
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Figures 
Figure 1. Aortic annulus measurements in a 3D Trans-esophageal echocardiography 
dataset 
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Figure 2. Long axis view of the aortic valve showing significant eccentric calcification 
on non-coronary cusp. 
  
35 
 
Figure 3. Typical examples of circular and ellipsoid aortic annulus shapes. Despite the 
difference in shape, the annular circumference is identical in both cases whereas the 
area is shrinking as the shape is becoming more ellipsoid. 
 
 
 
 
 
 
